SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roman S. who wrote (1071)6/11/1998 2:41:00 PM
From: Steven Messina,L.M.T.   of 1172
 
I do believe fears of an emminent (3-5) to 1 reverse split, terms of pending financing as well as the minimal $$ per quarter ($22k) Pfizer is allocating for test development, has left the masses quite perplexed and sheepish, imo.

We're going to need their PR dept to slap a more positive spin on things in the short term.

On a more optimistic note, I suppose we have this to look forward to:

ChemTrak will participate in the Equities Magazine Corporate Presentation Day IV Conference held at the Grand Hyatt Hotel in New York City on June 25, and will also participate in meetings with retail stockbrokers on the East Coast the same week.

regards,

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext